Potassium channels and transport systems (K+ channels)

Potassium channels and transport systems are a vast and diverse group of transmembrane proteins that facilitate the selective movement of potassium (K+) ions across cell membranes. These systems are critical for establishing and maintaining the resting membrane potential, as well as modulating the electrical excitability of neurons, muscle cells, and endocrine tissues (StatPearls, 2023). They are broadly categorized into several structural families, including voltage-gated (Kv), inward-rectifier (Kir), calcium-activated (KCa), and two-pore domain (K2P) channels, alongside various K+ transporters and pumps (IUPHAR/BPS Guide to Pharmacology). Malfunctions in these proteins, often termed channelopathies, are implicated in a wide range of disorders such as cardiac arrhythmias, epilepsy, and hyperinsulinemic hypoglycemia (PubMed, PMID: 29108545). Therapeutic agents targeting these systems function as either blockers, to prolong action potentials in the heart or increase insulin secretion, or openers, to reduce neuronal firing or relax vascular smooth muscle (Nature Reviews Drug Discovery, 2013). Given their ubiquitous presence throughout the body, achieving subtype selectivity is a major challenge in drug development to minimize off-target effects like cardiotoxicity or electrolyte imbalances (PubChem).

Other names

K+ channelsPotassium transportersK-channelsPotassium-selective ion channelsK+ transport systems

Potassium channel modulators function by either blocking the pore to inhibit K+ efflux, thereby prolonging the action potential duration (e.g., Class III antiarrhythmics), or by opening the channels to increase K+ conductance, which hyperpolarizes the cell and reduces excitability (e.g., K-ATP channel openers) (IUPHAR/BPS Guide to Pharmacology).